about
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015The role of antibiotics and probiotics in pouchitisMethodological considerations for future controlled influenza treatment trials in complementary and alternative medicine.Binaural beat technology in humans: a pilot study to assess psychologic and physiologic effects.Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazoleAntibiotics and probiotics in treatment of inflammatory bowel disease.Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial.Binaural beat technology in humans: a pilot study to assess neuropsychologic, physiologic, and electroencephalographic effects.Survey of CAM interest, self-care, and satisfaction with health care for type 2 diabetes at group health cooperative.Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancerAdjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one yearExpectancy, Self-Efficacy, and Placebo Effect of a Sham Supplement for Weight Loss in Obese Adults.Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa.Diffuse esophageal leiomyomatosis: case report and review.Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.Role of conventional therapies in the era of biological treatment in Crohn's disease.Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study.Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux.Applying principles from complex systems to studying the efficacy of CAM therapies.Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.A randomized pilot study of naturopathic medicine in multiple sclerosisImpact of interferon therapy on the natural history of hepatitis C virus related cirrhosis.Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease.Consensus Recommendations to NCCIH from Research Faculty in a Transdisciplinary Academic Consortium for Complementary and Integrative Health and Medicine.Patient-reported experiences with first-time naturopathic care for type 2 diabetesAsthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy.Algorithm for complementary and alternative medicine practice and research in type 2 diabetes.Long-term management of GERD in the elderly with pantoprazole.Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosisAscorbic acid and rates of cognitive decline in Alzheimer's disease.A pilot whole systems clinical trial of traditional Chinese medicine and naturopathic medicine for the treatment of temporomandibular disorders.The role of Budesonide-MMX in active ulcerative colitis.Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach.Distinct proteomic profiles characterise non-erosive from erosive reflux disease.The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis.Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment.The naturopathic medical research agenda: the future and foundation of naturopathic medical science.Treatment of human immunodeficiency virus-positive patients with complementary and alternative medicine: a survey of practitioners.Inflammatory Bowel Diseases and Spondyloarthropathies.
P50
Q26801010-335C1D93-3B5E-47C8-9A3F-BEED62808CE4Q27000314-54F79E59-5E9D-4637-AE15-BC04173CD16AQ30386172-D8F707DD-EE1B-4E27-992C-37AEC2D60247Q30542345-03BC8E8F-B121-4D36-84EC-50389CCE363CQ33413173-CA2DE0E0-05DF-41FC-96CE-103DB12B3D94Q33867934-2E06E646-7A72-4C58-852B-0BF3468EB89BQ33974381-4A8F3715-6F7D-4DF3-871C-EB8405E3B388Q34003182-B3C11494-D945-42AE-985C-06ED9E5A5086Q34088344-C8C4D065-5DA3-49BD-BE36-187EA9EB2DDAQ34116561-647ABD4C-0915-46AB-B2D8-D7C3E9E10F84Q34237460-42F6763D-F181-477F-8789-CAE4349D1CD9Q34276741-3F680DF7-D72A-4E92-99CA-0E866899AF35Q34539160-45AA6A0A-71A1-4926-A237-70558C103F71Q34582015-95178FB3-188B-4935-A64D-2E5A4213204AQ34588754-3E548276-EBBD-43C2-BD53-25BC0A4BC68DQ34831072-875FF0B6-EF2E-4396-AB98-8E2CCE16A96DQ34998108-F01C996B-A752-4FC8-BFF0-42206EC261DCQ35011174-28A447EA-7BFD-443A-8474-20E4AC48BCE4Q35033426-9325A08C-04A5-4007-8F27-14D89A029327Q35157475-61A7C2A6-D34F-4D07-94A4-5ABB897FA4FFQ35157941-716089F3-F9DD-4A81-A06B-1233A88DC667Q35363970-B5D926B9-0E40-4B1E-BAB5-6E8A969A783EQ35555687-62D123B7-DF52-4BD6-A2D4-354D03E3769CQ35861480-994712E1-CB00-4169-B7CF-B2697A109831Q36381151-5598F172-2663-48AF-8CD7-69DFADC727CCQ36503315-9AB20B59-82A8-4A01-B6F6-1F5524F04B40Q36739837-1C157830-DA3B-4B9D-B51D-ADD0CEEB9280Q37017283-E461A25D-8CF1-46C2-ADF4-EF34800D558DQ37118457-AF97BC2C-1498-4D31-8B68-09646C8369A8Q37162458-48BAC140-BE25-4FDC-B0BB-3649903CD49AQ37172100-C571DFA3-7B83-4918-A10E-8CBCC3FEF59BQ37373242-ABF75F2D-9457-4A03-B02E-6D7F81716C75Q38185703-36F1D367-8025-4E1A-8631-E6ACFB210437Q38253720-4CB3B54A-45DD-49DC-926F-32F9A8A69939Q38501133-E8335ECA-DA1E-4583-BE40-65065CCE1053Q38552422-E54A84ED-89C6-4307-95EB-0C39847A0DD9Q39370008-E3ADB225-968E-4B56-A243-A618C7E7A85AQ40329769-79BD2E7E-D41D-4D16-BA5F-2891B4F46DD5Q40840613-A23E80E9-8982-47C8-8F54-7748888D0010Q41160263-E307C537-F91B-4C51-8E4E-68AA5D60775A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlo Calabrese
@ast
Carlo Calabrese
@en
Carlo Calabrese
@es
Carlo Calabrese
@nl
Carlo Calabrese
@sl
type
label
Carlo Calabrese
@ast
Carlo Calabrese
@en
Carlo Calabrese
@es
Carlo Calabrese
@nl
Carlo Calabrese
@sl
prefLabel
Carlo Calabrese
@ast
Carlo Calabrese
@en
Carlo Calabrese
@es
Carlo Calabrese
@nl
Carlo Calabrese
@sl
P106
P1153
18333880300
P21
P31
P496
0000-0003-3657-4463